Literature DB >> 15657354

Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.

Rebecca P Danam1, Sherie R Howell, Thomas P Brent, Linda C Harris.   

Abstract

Transcriptional silencing of the DNA repair gene, O6-methylguanine-DNA methyltransferase (MGMT) in a proportion of transformed cell lines is associated with methylated CpG hotspots in the MGMT 5' flank. The goal of the study was to evaluate the mechanism by which CpG methylation of theMGMT promoter region influenced silencing of the gene. Analysis of histone acetylation status in two regions of the promoter using chromatin immunoprecipitation assay showed that a higher level of histone acetylation was associated with expression in three MGMT-expressing cell lines (HeLa CCL2, HT29, and Raji) compared with three MGMT-silenced cell lines (HeLa S3, BE, and TK6). To determine how the modulation of CpG methylation and histone acetylation influenced MGMT expression, we exposed the cells to 5-aza-2'deoxycytidine (5-Aza-dC), inhibitor of DNA methylation, which strongly up-regulated MGMT expression in three MGMT-silenced cell lines whereas trichostatin A, inhibitor of histone deacetylase, weakly induced MGMT. However, combined treatment with 5-Aza-dC and trichostatin A significantly up-regulated MGMT RNA expression to a greater extent than in cells treated with either agent alone suggesting that histone deacetylation plays a role in MGMT silencing but that CpG methylation has a dominant effect. Consistent with enhanced MGMT expression, 5-Aza-dC increased the association of acetylated histone H3 and H4 bound to the MGMT promoter. Chromatin immunoprecipitation analysis of methyl-CpG binding domain containing proteins detected a greater amount of MeCP2, MBD1, and CAF-1 bound to the MGMT promoter in MGMT-silenced cells. Our findings implicate specific MBD proteins in methylation-mediated transcriptional silencing of MGMT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657354

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  22 in total

1.  Altered methylation of the DNA repair gene MGMT is associated with neural tube defects.

Authors:  Susanna Tran; Li Wang; Jing Le; Jing Guan; Lihua Wu; Jizhen Zou; Zhen Wang; Jianhua Wang; Fang Wang; Xiaoli Chen; Lingling Cai; Xiaolin Lu; Huizhi Zhao; Jin Guo; Yihua Bao; Xiaoying Zheng; Ting Zhang
Journal:  J Mol Neurosci       Date:  2011-11-19       Impact factor: 3.444

2.  Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.

Authors:  Yan Y Sanders; Trygve O Tollefsbol; Brian M Varisco; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

3.  DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status.

Authors:  B L Pike; T C Greiner; X Wang; D D Weisenburger; Y-H Hsu; G Renaud; T G Wolfsberg; M Kim; D J Weisenberger; K D Siegmund; W Ye; S Groshen; R Mehrian-Shai; J Delabie; W C Chan; P W Laird; J G Hacia
Journal:  Leukemia       Date:  2008-02-21       Impact factor: 11.528

4.  Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma.

Authors:  Michael D Blough; Desiree C Beauchamp; Morgan R Westgate; John J Kelly; J Gregory Cairncross
Journal:  J Neurooncol       Date:  2010-07-01       Impact factor: 4.130

Review 5.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

Review 6.  O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problems.

Authors:  John R Silber; Michael S Bobola; A Blank; Marc C Chamberlain
Journal:  Biochim Biophys Acta       Date:  2012-01-08

7.  MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression.

Authors:  Meixiang Xu; Courtney E Cross; Jordan T Speidel; Sherif Z Abdel-Rahman
Journal:  Cell Oncol (Dordr)       Date:  2016-06-15       Impact factor: 6.730

8.  MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma.

Authors:  L Toffolatti; E Scquizzato; S Cavallin; F Canal; M Scarpa; P M Stefani; F Gherlinzoni; A P Dei Tos
Journal:  Virchows Arch       Date:  2014-07-17       Impact factor: 4.064

9.  DNA methylation and histone acetylation regulate the expression of MGMT and chemosensitivity to temozolomide in malignant melanoma cell lines.

Authors:  Ya-Ping Chen; Xiao-Yang Hou; Chun-Sheng Yang; Xiao-Xiao Jiang; Ming Yang; Xi-Feng Xu; Shou-Xin Feng; Yan-Qun Liu; Guan Jiang
Journal:  Tumour Biol       Date:  2016-03-04

10.  Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model.

Authors:  Gaspar J Kitange; Brett L Carlson; Ann C Mladek; Paul A Decker; Mark A Schroeder; Wenting Wu; Patrick T Grogan; Caterina Giannini; Karla V Ballman; Jan C Buckner; C David James; Jann N Sarkaria
Journal:  J Neurooncol       Date:  2008-11-15       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.